Integral Derivatives’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-23,400
Closed -$1.49M 1314
2017
Q3
$1.49M Buy
+23,400
New +$1.47M 0.03% 382
2017
Q2
Sell
-6,900
Closed -$368K 1317
2017
Q1
$368K Sell
6,900
-900
-12% -$48.6K 0.01% 834
2016
Q4
$418K Sell
7,800
-7,900
-50% -$402K 0.01% 784
2016
Q3
$817K Buy
+15,700
New +$795K 0.02% 485
2016
Q1
Sell
-20,100
Closed -$963K 1148
2015
Q4
$963K Buy
20,100
+14,300
+247% +$646K 0.02% 476
2015
Q3
$239K Buy
+5,800
New +$269K 0.01% 926
2015
Q1
Sell
-4,700
Closed -$202K 1433
2014
Q4
$202K Buy
+4,700
New +$191K ﹤0.01% 1229
2014
Q3
Sell
-11,500
Closed -$371K 1573
2014
Q2
$371K Buy
+11,500
New +$353K 0.01% 1029

Other funds holding ZTS

Integral Derivatives's ZTS Position: Q4 2016 in Review

Integral Derivatives sold out of Zoetis (ZTS) in Q4 2016, closing a stake of 8,326 shares — an estimated $423K sold.

Integral Derivatives first reported a position in ZTS in Q3 2016 and held it in 1 quarter. The position peaked at $433K in Q3 2016. 692 funds tracked by Wall St. Rank hold ZTS as of Q4 2016.

  • Integral Derivatives reported no remaining Zoetis position as of Q4 2016 after selling out during the quarter.
  • Integral Derivatives sold 8,326 Zoetis shares in Q4 2016, an estimated $423K.
  • Integral Derivatives first reported a position in Zoetis in Q3 2016 and held it in 1 quarter.
  • Integral Derivatives's Zoetis position peaked at $433K in Q3 2016.
  • 692 funds tracked by Wall St. Rank held Zoetis as of Q4 2016.

Based on Integral Derivatives's 13F filing for Q4 2016, filed 14 Feb 2017.